|
시장보고서
상품코드
1890967
로사르탄 칼륨 정제 시장 : 강도별, 적응증별, 연령층별, 유형별, 제제 유형별, 포장 유형별, 유통 채널별, 최종사용자별, 지역별Losartan Potassium Tablets Market, By Strength, By Indication, By Age Group, By Type, By Formulation Type, By Packaging Type, By Distribution Channel, By End User, By Geography |
||||||
로사르탄 칼륨 정제 시장은 2025년에 26억 4,000만 달러로 추정되며, 2032년까지 41억 3,000만 달러에 달할 것으로 예측됩니다. 2025-2032년까지 CAGR 6.6%로 성장할 것으로 전망됩니다.
| 보고서 커버 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2024년 | 2025년 시장 규모: | 26억 4,000만 달러 |
| 과거 데이터 대상 기간: | 2020-2024년 | 예측 기간: | 2025-2032년 |
| 예측 기간 2025-2032년: | 6.60% | 2032년 예측치: | 41억 3,000만 달러 |
세계 로사르탄 칼륨 정제 시장은 심혈관계 의약품 산업에서 중요한 부분을 차지하고 있으며, 전 세계적으로 만연한 고혈압 및 관련 심혈관계 질환에 대응하고 있습니다. 안지오텐신 수용체 길항제(ARB)인 로사르탄 칼륨은 안지오텐신 II 수용체를 선택적으로 차단하여 혈관 수축과 알도스테론 분비를 억제하는 작용을 합니다. 이는 혈압을 낮추고 심혈관계 결과를 개선하는 데 도움이 됩니다.
이 치료법은 ACE 억제제 대비 부작용 프로파일이 우수하고, 특히 마른기침이 발생하지 않아 고혈압 치료에 대한 내약성 문제가 있는 환자들에게 선호되는 치료법으로 주목받고 있습니다. 이 시장은 다양한 용량 강도와 제형을 포함하고 있으며, 다양한 지역에 걸쳐 다양한 환자층을 대상으로 하고 있습니다. 전 세계 심혈관질환 부담 증가, 인구 고령화, 고혈압 관리에 대한 인식이 높아짐에 따라 로사르탄 칼륨 정제에 대한 수요는 지속적으로 크게 증가하고 있습니다. 시장 역학은 특허 만료에 따른 제네릭 의약품과의 경쟁, 새로운 제형의 규제 승인, 신흥국의 의료 인프라 구축, 주요 심장병 학회의 치료 가이드라인 개정 등의 요인에 영향을 받고 있으며, 이 시장은 광범위한 항고혈압 치료제 시장에서 중요한 구성요소로 자리매김하고 있습니다.
시장 역학
세계 로사르탄 칼륨 정제 시장은 견고한 성장 궤도를 뒷받침하는 여러 강력한 촉진요인에 의해 주도되고 있습니다. 주요 촉매제는 세계보건기구(WHO) 추산에 따르면 전 세계적으로 11억 3,000만 명 이상이 앓고 있는 고혈압 유병률의 증가와 심혈관 위험 관리 및 조기 개입 전략에 대한 인식이 높아진 것입니다. 고령화되는 세계 인구구조도 시장 확대에 크게 기여하고 있습니다. 고혈압 발병률은 나이가 들면서 현저하게 증가하는 반면, 좌식 생활습관, 고나트륨 섭취, 스트레스 관련 요인 등 생활습관의 변화로 인해 항고혈압 치료가 필요한 환자층이 더욱 확대되고 있기 때문입니다. 또한, ACE 억제제 대비 ARB(안지오텐신 수용체 길항제)의 우수한 내약성 프로파일, 특히 혈관성 부종과 지속성 마른기침이 발생하지 않는 점은 의사의 선택과 환자의 복약 순응도를 높여 시장 수요를 지속시키고 있습니다.
그러나 시장에는 눈에 띄는 제약도 존재합니다. 브랜드 의약품의 특허만료에 따른 치열한 제네릭 의약품 경쟁은 제조업체에게 큰 폭의 가격 하락과 수익률 압박을 가져옵니다. 또한, 의약품 승인 및 제조 컴플라이언스에 대한 엄격한 규제 요건은 막대한 운영 비용과 개발 기간의 연장을 강요하는 요인으로 작용합니다. 또한, 칼슘길항제, 베타차단제, 신규 복합제 등 대체할 수 있는 항고혈압제 계열의 존재는 시장 점유율 확대에 대한 경쟁적 압력을 야기하고 있습니다. 그러나 아시아태평양, 라틴아메리카, 아프리카 등 신흥 시장의 의료 인프라 확충, 의료비 지출 증가, 의약품 접근성 향상으로 인해 큰 기회가 창출되고 있습니다. 로사르탄과 보완적인 항고혈압제를 결합한 혁신적인 병용요법 개발은 수익성 높은 성장 채널을 제공하고, 디지털 헬스와의 통합 및 맞춤형 의료 접근은 환자 모니터링 강화 및 치료 최적화 가능성을 제시하며, 경쟁적 도전에도 불구하고 시장의 지속적이고 장기적인 확장을 가능케 합니다.
본 조사의 주요 특징
- 세계의 로사르탄 칼륨 정제 시장에 대한 상세한 분석을 제공하여 2024년을 기준 연도, 예측 기간(2025-2032년) 동안 시장 규모(10억 달러)와 CAGR%를 조사하여 예측한 보고서입니다.
- 본 보고서에서는 다양한 부문의 잠재적 수익기회를 확인하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
- 시장 촉진요인, 저해요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 시장 진입업체들의 경쟁 전략에 대한 주요 조사결과를 정리하여 전해드립니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계 로사르탄 칼륨 정제 시장의 주요 기업을 프로파일링합니다. 기업 개요,제품 포트폴리오,주요 특징,재무실적,전략
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 로사르탄 칼륨 정제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 금융 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 로사르탄 칼륨 정제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것으로 보입니다.
목차
제1장 조사 목적과 가정
- 조사 목적
- 가정
- 약어
제2장 시장 범위
- 보고서 개요
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 규제 환경
- 제품 발매·승인
- PEST 분석
- Porters 분석
- 인수합병 동향
- 산업 동향
제4장 세계의 로사르탄 칼륨 정제 시장 : 강도별, 2020-2032년
- 25mg
- 50mg
- 100mg
제5장 세계의 로사르탄 칼륨 정제 시장 : 적응증별, 2020-2032년
- 고혈압
- 좌심실 비대(LVH)를 수반하는 고혈압 환자
- 신증을 수반하는 2형 당뇨병
제6장 세계의 로사르탄 칼륨자물쇠 시장 : 연령층별, 2020-2032년
- 성인
- 소아
- 노인
제7장 세계의 로사르탄 칼륨자물쇠 시장 : 유형별, 2020-2032년
- 브랜드
- 제네릭
제8장 세계의 로사르탄 칼륨 정제 시장 : 제제 유형별, 2020-2032년
- 즉방성 정제
- 서방형 정제
제9장 세계의 로사르탄 칼륨 정제 시장 : 포장 유형별, 2020-2032년
- 블리스터
- 보틀
- 스트립
제10장 세계의 로사르탄 칼륨자물쇠 시장 : 유통 채널별, 2020-2032년
- 병원 약국
- 소매 약국
- 온라인 약국
제11장 세계의 로사르탄 칼륨자물쇠 시장 : 최종사용자별, 2020-2032년
- 병원
- 클리닉
- 외래 수술 센터
- 재택의료 시설
제12장 세계의 로사르탄 칼륨자물쇠 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카 국가
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC
- 이스라엘
- 기타 중동 국가
- 아프리카
- 남아프리카공화국
- 북아프리카
- 중앙아프리카
제13장 경쟁 구도
- Merck(MSD)
- Teva Pharmaceutical Industries
- Torrent Pharmaceuticals
- Sun Pharmaceutical Industries
- Reddy's Laboratories
- Aurobindo Pharma
- Lupin Limited
- Zydus Lifesciences
- Alembic Pharmaceuticals
- Viatris(Mylan)
- Apotex Inc.
- Hikma Pharmaceuticals
- Cipla Limited
- Sandoz(Novartis 부서)
- Intas Pharmaceuticals
제14장 애널리스트의 추천사항
- 기회
- Coherent Opportunity Map
제15장 참고문헌과 조사 방법
- 참고문헌
- 조사 방법
- 출판사 소개
Losartan Potassium Tablets Market is estimated to be valued at USD 2.64 Bn in 2025 and is expected to reach USD 4.13 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 2.64 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.60% | 2032 Value Projection: | USD 4.13 Bn |
The global losartan potassium tablets market represents a crucial segment within the cardiovascular pharmaceutical industry, addressing the widespread prevalence of hypertension and related cardiovascular disorders worldwide. Losartan potassium, an Angiotensin Receptor Blocker (ARB), functions by selectively blocking angiotensin II receptors, thereby preventing vasoconstriction and aldosterone secretion, which ultimately leads to reduced blood pressure and improved cardiovascular outcomes.
This therapeutic class has gained significant traction due to its favorable side effect profile compared to ACE inhibitors, particularly the absence of dry cough, making it a preferred choice for patients with hypertension intolerance issues. The market encompasses various dosage strengths and formulations, catering to diverse patient populations across different geographical regions. With the increasing global burden of cardiovascular diseases, aging demographics, and rising awareness about hypertension management, the demand for Losartan Potassium Tablets continues to expand substantially. The market dynamics are influenced by factors including patent expirations leading to generic competition, regulatory approvals for new formulations, healthcare infrastructure development in emerging economies, and evolving treatment guidelines from major cardiology associations, positioning this market as a vital component of the broader antihypertensive therapeutics landscape.
Market Dynamics
The global losartan potassium tablets market is propelled by several compelling drivers that underscore its robust growth trajectory, with the primary catalyst being the escalating prevalence of hypertension globally, affecting over 1.13 billion people worldwide according to WHO estimates, coupled with increasing awareness about cardiovascular risk management and early intervention strategies. The aging global population demographic significantly contributes to market expansion, as hypertension incidence rises substantially with age, while lifestyle changes including sedentary behavior, high sodium intake, and stress-related factors further amplify the patient pool requiring antihypertensive therapy. Additionally, the superior tolerability profile of ARBs compared to ACE inhibitors, particularly the absence of angioedema and persistent dry cough, drives physician preference and patient compliance, thereby sustaining market demand.
However, the market faces notable restraints including intense generic competition following patent expirations of branded formulations, leading to significant price erosion and margin compression for manufacturers, while stringent regulatory requirements for drug approval and manufacturing compliance impose substantial operational costs and timeline extensions. Furthermore, the availability of alternative antihypertensive classes such as calcium channel blockers, beta-blockers, and newer combination therapies creates competitive pressure on market share growth. Nevertheless, substantial opportunities emerge from expanding healthcare infrastructure in developing economies, increasing healthcare expenditure, and growing pharmaceutical access in emerging markets including Asia-Pacific, Latin America, and Africa. The development of innovative combination therapies incorporating losartan with complementary antihypertensive agents presents lucrative growth avenues, while digital health integration and personalized medicine approaches offer potential for enhanced patient monitoring and treatment optimization, positioning the market for sustained long-term expansion despite competitive challenges.
Key Features of the Study
- This report provides in-depth analysis of the global losartan potassium tablets market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global losartan potassium tablets market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Merck and Co. (MSD), Teva Pharmaceutical Industries, Torrent Pharmaceuticals, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Aurobindo Pharma, Lupin Limited, Zydus Lifesciences, Alembic Pharmaceuticals, Viatris (Mylan), Apotex Inc., Hikma Pharmaceuticals, Cipla Limited, Sandoz (Novartis Division), and Intas Pharmaceuticals
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global losartan potassium tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global losartan potassium tablets market
Market Segmentation
- Strength Insights (Revenue, USD Bn, 2020 - 2032)
- 25 mg
- 50 mg
- 100 mg
- Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Hypertension
- Hypertensive Patients with Left Ventricular Hypertrophy (LVH)
- Type 2 Diabetes with Nephropathy
- Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adult
- Pediatric
- Geriatric
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Branded
- Generic
- Formulation Type Insights (Revenue, USD Bn, 2020 - 2032)
- Immediate-Release Tablets
- Extended-Release Tablets
- Packaging Type Insights (Revenue, USD Bn, 2020 - 2032)
- Blister Packs
- Bottles
- Strip Packs
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Homecare Settings
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Merck (MSD)
- Teva Pharmaceutical Industries
- Torrent Pharmaceuticals
- Sun Pharmaceutical Industries
- Reddy's Laboratories
- Aurobindo Pharma
- Lupin Limited
- Zydus Lifesciences
- Alembic Pharmaceuticals
- Viatris (Mylan)
- Apotex Inc.
- Hikma Pharmaceuticals
- Cipla Limited
- Sandoz (Novartis Division)
- Intas Pharmaceuticals
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Losartan Potassium Tablets Market, By Strength
- Global Losartan Potassium Tablets Market, By Indication
- Global Losartan Potassium Tablets Market, By Age Group
- Global Losartan Potassium Tablets Market, By Type
- Global Losartan Potassium Tablets Market, By Formulation Type
- Global Losartan Potassium Tablets Market, By Packaging Type
- Global Losartan Potassium Tablets Market, By Distribution Channel
- Global Losartan Potassium Tablets Market, By End User
- Global Losartan Potassium Tablets Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Losartan Potassium Tablets Market, By Strength, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- 25 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 50 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 100 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Losartan Potassium Tablets Market, By Indication, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hypertensive Patients with Left Ventricular Hypertrophy (LVH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Type 2 Diabetes with Nephropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Losartan Potassium Tablets Market, By Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Losartan Potassium Tablets Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Losartan Potassium Tablets Market, By Formulation Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Immediate-Release Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Extended-Release Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Losartan Potassium Tablets Market, By Packaging Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Blister Packs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Bottles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Strip Packs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Losartan Potassium Tablets Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Losartan Potassium Tablets Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
12. Global Losartan Potassium Tablets Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
13. Competitive Landscape
- Merck (MSD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Torrent Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reddy's Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aurobindo Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lupin Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zydus Lifesciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alembic Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Viatris (Mylan)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Apotex Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hikma Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cipla Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sandoz (Novartis Division)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Intas Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
